Sartorius Stedim Biotech S.A. (ETR:56S1)

Market Cap	20.63B
Revenue (ttm)	2.86B
Net Income (ttm)	204.30M
Shares Out	n/a
EPS (ttm)	2.11
PE Ratio	100.97
Forward PE	n/a
Dividend	0.69 (0.34%)
Ex-Dividend Date	Apr 2, 2025

Volume	n/a
Average Volume	153
Open	210.70
Previous Close	211.30
Day's Range	210.70 - 210.70
52-Week Range	144.80 - 235.20
Beta	n/a
RSI	66.73
Earnings Date	Apr 16, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Laboratory Analytical Instruments
• Founded: 1978
• Employees: 9,901
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 56S1

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.